![](https://www.lachmanconsultants.com/wp-content/uploads/2023/10/Guidance_Blog_Pic.png)
Dissemination of Articles and Study Results, New Revised Q&A Draft Guide May Provide Better Direction
Yesterday, the FDA issued a draft guidance titled “Communications From Firms to Health Care Providers Regarding Scientific Information on Unapproved Uses of Approved/Cleared Medical Products: Questions and Answers” (here). If you can get that out of your mouth without taking a breath, I think you must be a free diver. The issue of disseminating information […]